D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to...

download D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates the question asked in NRDC

of 26

Transcript of D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to...

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    1/26

    !"#$%& !"#$%& ( )&$*+, -./.6*%; & 8: (9,"$ 5?8=

    Omti tm usirs> Krtdajis do tbi ‒Ipuls kbik` mc prdot— (IKV) siatdmo kri piirrivdiwi` kaaipti` krtdajis tm li puljdsbi` do tbds nmurokj. Vjiksi li kwkri tbktkjtbmugb IKVs `m omt bkvi kjj ldljdmgrkpbda `itkdjs kvkdjklji yit, tbiy ako liadti` usdog tbi yikr mc mojdoi puljdaktdmo ko` tbi @dgdtkj Mlniat D`iotdcdir (@MD)ks cmjjmws> Kutbmr(s), ‒Krtdaji Pdtji—, Nmurokj (Tikr), @MD, IKV (pkgi #).

    Pbi IKV pkgi ouelir wdjj li ritkdoi` do tbi lmttme ekrgdo mc tbi prdoti`virsdmo mc tbds krtdaji wbio dt ds amjjkti` do k prdot dssui. Amjjkti` prdot virsdmosmc tbi krtdaji wdjj amotkdo ko k``dtdmokj vmjueitrda pkgi ouelir. Lmtb pkgiadtktdmos wdjj li rijivkot, lut koy IKV ricirioai eust amotdoui tm li priai`i` ly tbi jittirs IKV.

    DQQO-67//www.njdsnmurokj.mrg/

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    2/26

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    3/26

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    4/26

     Nmurokj mc Jkw, Docmrektdmo ko` Qadioai Smj

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    5/26

    @—Kray v Eyrdk` Gioitdas Doa X Pbi pjurkjdty—s oiw ckatmrdkj kpprmkab tm pktiotkldjdty rikrtdaujktis tbi quistdmo kshi` do O\@A

    IKV 1

    pktiotkldjdty mc dsmjkti` gioi siquioais (lmtb @OK ko` a@OK) do jdgbt mc tbiKustrkjdko Vktiot Mccdai—s okrrmw rik`dog mc tbi `iadsdmo8;;  (dd) tbi icciat mc tbipjurkjdty—s ‒ameemo jkw eitbm`mjmgy—; (d) tbi kppjdaklji sadioaikt dssui8 (dd)  @—Kray—s ckatukj ektrdx8 (ddd) tbi rijivkot Kustrkjdko stktutmryriqudrieiots cmr pktiotkldjdty8 ko` (dv) tbi kpprmkab jkd` `mwo ly tbi BdgbAmurt—s siedokj `iadsdmo do O\@A.

    ;.; Qbmrt prä

    ads mo kppjdaklji sadioai

    Pbi ajkdes do sudt licmri tbi Bdgb Amurt rijkti` tm @OK ko` a@OK tbkt bk` liio dsmjkti` ko` ixtrkati` crme tbi bueko lm`y. @OK (`imxyrdlmouajidakad`) ds tbi lksda ‒ludj`dog ljmah— mc k aijj, ks dt amotkdos k sit mc ouajimtd`iswbdab ‒doamrpmrktis k ‚gioitda am`i― tbkt `icdois tbi grmwtb, `ivijmpeiot,ekdotiokoai ko` riprm`uatdmo mc tbi bueko lm`y—.;0  Pbi @OK dsmjkti` lyEyrdk` Gioitdas Doa amotkdoi` k sirdis mc ouajimtd`is wbdab am`i` cmrpmjypiptd`i akjji` tbi L\KA; gioi, wbdab amosdsti` mc eutktdmos skd` tmdo`dakti k pri`dspmsdtdmo tm lrikst akoair.;9 

    Eyrdk` Gioitdas— lrikst akoair tistdog dsmjkti` k pktdiot—s @OK do kaamr`koaiwdtb kaaipti` prmaissis (lrikhdog `mwo tbi amvkjiot lmo`s tm ixtrkat tbi@OK) wbdab ioklji` tbi `itiredoktdmo mc wbitbir k pktdiot bk` ko ijivkti`rdsh mc lrikst akoair, k `itiredoktdmo omt klji tm li ek`i dc tbi @OK wks jict dodts oktdvi stkti. Amepjieiotkry @OK (a@OK), wbdab ds kjsm klji tm lisyotbisdsi` `urdog tbisi kaaipti` prmaissis, wks kjsm sulniat tm abkjjiogi do@—Kray `ui tm dts sdedjkrdty wdtb @OK.

    ;; Kustrkjdko Vktiot Mccdai, Ixkedoktdmo Vrkatdai cmjjmwdog tbi Bdgb Amurt `iadsdmo do@—Kray v Eyrdk` Gioitdas Doa  (;3 @iaielir //www.dpkustrkjdk.gmv.ku/p`cs/amosujtkdtmo]suledssdmos/

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    6/26

     Nmurokj mc Jkw, Docmrektdmo ko` Qadioai Smj

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    7/26

    @—Kray v Eyrdk` Gioitdas Doa X Pbi pjurkjdty—s oiw ckatmrdkj kpprmkab tm pktiotkldjdty rikrtdaujktis tbi quistdmo kshi` do O\@A

    IKV 9

    ;.1 Pbi s ;2(;)(k) riqudrieiot cmr pktiotkldjdty do Kustrkjdk

    Do Kustrkjdk, s ;2(;)(k) mc tbi Vktiots Kat ;446 (Atb) prmvd`is tbkt ko ‒doviotdmo—ds pktiotklji dc dt ds ‒k ekooir mc ekouckaturi wdtbdo tbi eikodog mc s 3 mc tbi

    Qtktuti mc Emompmjdis—. Pbi iotry dotm cmrai mc tbi Iogjdsb Qtktuti mc Emompmjdis

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    8/26

     Nmurokj mc Jkw, Docmrektdmo ko` Qadioai Smj

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    9/26

    @—Kray v Eyrdk` Gioitdas Doa X Pbi pjurkjdty—s oiw ckatmrdkj kpprmkab tm pktiotkldjdty rikrtdaujktis tbi quistdmo kshi` do O\@A

    IKV 7

    omti` klmvi, tbi ckat tbkt tbi docmrektdmokj amotiot do tbi dsmjkti` @OK wks tbiskei ks tbi @OK ‒amotkdoi` do tbi @OK mc tbi pirsmo crme wbdab tbi ouajidakad` wks dsmjkti`—0;  prmvd`i` tbi ujtdekti nustdcdaktdmo cmr tbi Bdgb Amurtpjurkjdty tm rik` tbi ajkdes gioitdakjjy.

    koy pmtiotdkjjy oigktdvi icciatsmo doomvktdmo8 koy pmtiotdkj mc abdjjdog icciat mo katdvdtdis liymo` tbmsicmrekjjy tbi sulniat mc ixajusdvi pktiot rdgbts8 ko` koy oii` cmr tbiamurt tm kssiss puljda ko` prdvkti dotirists)8 09 

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    10/26

     Nmurokj mc Jkw, Docmrektdmo ko` Qadioai Smj

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    11/26

    @—Kray v Eyrdk` Gioitdas Doa X Pbi pjurkjdty—s oiw ckatmrdkj kpprmkab tm pktiotkldjdty rikrtdaujktis tbi quistdmo kshi` do O\@A

    IKV 4

    kgkdost tbi kppjdaktdmo mc tbi oiw tist kri tbkt tbi riksmodog ko` ckatmrs `m omtprmvd`i gud`koai mo> bmw tbiy kri tm li kssissi`, 97  omr tbi widgbt tm likccmr`i` tm do`dvd`ukj ckatmrs,92 mr priadsijy wbdab ckatmrs eust li amosd`iri` dok pkrtdaujkr aksi.94 

    Tit, `ispdti tbisi do`dateiots, tbi ameemo jkw bdstmrdakj rmmts36  mc sulniatekttir pktiotkldjdty eiko tbkt, ks krgui` ly Qbireko>

    tbi riksmos cmr tbi doajusdmo ko` ixajusdmo mc sulniat ekttir akoomt li ri`uai`tm k sit mc ‒prdoadpjis— (ks wks suggisti` do O\@A). Dostik`, pktiotklji sulniatekttir ds `itiredoi` ly ko krrky mc ckatmrs.3; 

    Pbiricmri, tbi pjurkjdty, ly ixprissjy riniatdog tbi mrtbm`mx ldokry kppjdaktdmo3

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    12/26

     Nmurokj mc Jkw, Docmrektdmo ko` Qadioai Smj

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    13/26

    @—Kray v Eyrdk` Gioitdas Doa X Pbi pjurkjdty—s oiw ckatmrdkj kpprmkab tm pktiotkldjdty rikrtdaujktis tbi quistdmo kshi` do O\@A

    IKV ;;

    amosd`ir sulniat ekttir kt tbi lmr`irjdoi mc pktiotkldjdty pmst-@—Kray. Do \VJ ,Hiooy, Liooitt ko` Odabmjks NN uokodemusjy cmuo` tbkt tbi ameputir-depjieioti` lusdoiss eitbm` ajkde do sudt `d` omt rikab @—Kray—s  tbrisbmj`riqudrieiot mc ‒k oiw ajkss mc ajkde dovmjvdog k sdgodcdakot ixtiosdmo mc tbi

    amoaipt mc ekooir mc ekouckaturi—.79

      Ks suab, tbi Amurt amrriatjy bij` tbkt dtwks omt oiaisskry tm amosd`ir tbi oiw ckatmrs prmpmuo`i` ly tbi pjurkjdty. PbiAmurt—s riksmodog, do issioai, wks tbkt tbi ajkdei` ‒eitbm` `mis omt doaju`ikoy stips tbkt kri mutsd`i tbi omrekj usi mc k ameputir—,73 k amoajusdmo rikabi`‒ly kppjydog tbi istkljdsbi` prdoadpjis ks tbiy rijkti tm k ameputir-depjieioti` lusdoiss eitbm`—.77  Ks suledtti` do tbi pkrkgrkpb klmvi, tbisi‒istkljdsbi` prdoadpjis— kri tbi ixtkot riksmodog `irdvi` crme O\@A  nurdspru`ioai, wbdab ako ujtdektijy li ixprissi` ly tbi twm ckatmrs stkti` ktX

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    14/26

     Nmurokj mc Jkw, Docmrektdmo ko` Qadioai Smj (d) Kustrkjdko Jkw \icmreAmeedssdmo \ipmrt Om 44823  (dd) tbi Qiokti—s riniatdmo mc keio`eiots tm tbiVktiots Ldjj ;446 (Atb)827 ko` (ddd) tbi Jigkj ko` Amostdtutdmokj Kcckdrs JigdsjktdmoAmeedttii mc tbi Qiokti—s riniatdmo mc tbi Vktiot Keio`eiot (Bueko Giois

    ko` Ldmjmgdakj Ektirdkjs) Ldjj

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    15/26

    @—Kray v Eyrdk` Gioitdas Doa X Pbi pjurkjdty—s oiw ckatmrdkj kpprmkab tm pktiotkldjdty rikrtdaujktis tbi quistdmo kshi` do O\@A

    IKV ;1

    omt ixajusdmo—46  crme pktiotkldjdty. Dt eky li krgui` tbds riqudrieiot cmr tbijigdsjkturi tm doaju`i oiw ajkssis mc ajkdes k``s komtbir lkrrdir tm pktiotkldjdtycmr sulniat ekttir kt tbi lmr`irjdoi mc pktiotkldjdty ko` ds tbiricmri ko‒dovirsdmo— mc tbi rigdei prisardli` ly tbi Kat. Do k``dtdmo, dt ds suledtti` tbkt

    tbds riksmodog ds `dsamr`kot wdtb Ariooko ko` Hdicij NN—s (wdtb Gkgijir Nkgriidog) riksmodog do Kpmtix. Pbidr Bmomurs— riksmodog wks tbkt tbi klsioai mckoy ixpriss mr depjdi` ixajusdmo mc tbi sulniat ekttir kt dssui do tbkt aksi wks kstrmog riksmo do ckvmur mc kaamr`dog pktiotkldjdty.4;  \igkr`jiss mc wbitbir tbipjurkjdty—s riksmodog mo jigdsjktdvi doajusdmo wks sud gioirds, dt ds suledtti` tbktsuab riksmodog ds k oiaisskry dotigir do tbi pjurkjdty—s lrmk`ir cdo`dog tbkt dtwks `dsabkrgdog dts nu`dadkj cuoatdmo kaamr`dog tm tbi ameemo jkw eitbm` (siicurtbir Vkrt 1.< lijmw).

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    16/26

     Nmurokj mc Jkw, Docmrektdmo ko` Qadioai Smj

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    17/26

    @—Kray v Eyrdk` Gioitdas Doa X Pbi pjurkjdty—s oiw ckatmrdkj kpprmkab tm pktiotkldjdty rikrtdaujktis tbi quistdmo kshi` do O\@A

    IKV ;9

    rijdi` mo k uokodemus Bdgb Amurt do Ameedssdmoir mc Vktiots v Edarmaijj;61 wbdabbij` ko doviotdmo amuj` li `iodi` pktiotkldjdty mo tbi lksds tbi ckai tbispiadcdaktdmo `d` omt `dsajmsi tbi k succdadiot `igrii mc doviotdvioiss tmamostdtuti ‒ekooir mc ekouckaturi—.;60 Gkgijir ko` Oittji NN curtbir rijdi` mo OS

    Vbdjdps Gjmidjkepiocklrdihio v Edrklijjk Dotiroktdmokj Vty Jt  ̀,;69

      wbiri Lriooko,@ikoi ko` Pmmbiy NN bij` tbiri ds k ‒oiaisskry qukjdty mc doviotdvioiss—;63 riqudri` licmri ko doviotdmo wdjj li k ekooir mc ekouckaturi wdtbdo tbieikodog mc s 3 mc tbi Qtktuti mc Emompmjdis.

    Tit do Jmahwmm` Qiaurdty Vrm`uats Vty Jt` v @mrda Vrm`uats Vty Jt` XOm

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    18/26

     Nmurokj mc Jkw, Docmrektdmo ko` Qadioai Smj

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    19/26

    @—Kray v Eyrdk` Gioitdas Doa X Pbi pjurkjdty—s oiw ckatmrdkj kpprmkab tm pktiotkldjdty rikrtdaujktis tbi quistdmo kshi` do O\@A

    IKV ;7

    1.; Deei`dkti amosiquioais cmr pktiots mc dsmjkti` ko` syotbisdsi`gioi siquioais ‑ @OK, \OK ko` a@OK

    @—Kray  bks arikti` k `igrii mc uoairtkdoty ks tm tbi pktiotkldjdty mc dsmjkti`

    gioi siquioais, wdtb pkrtdaujkr do`ustry amoairo `driati` tmwkr`s tbiijdgdldjdty mc syotbisdsi` a@OK. Deei`dktijy cmjjmwdog tbi nu`geiot, smeiameeiotktmrs rik` tbi pjurkjdty nu`geiot viry okrrmwjy ko` amocdoi` @—Kray tm dts ckats,;

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    20/26

     Nmurokj mc Jkw, Docmrektdmo ko` Qadioai Smj

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    21/26

    @—Kray v Eyrdk` Gioitdas Doa X Pbi pjurkjdty—s oiw ckatmrdkj kpprmkab tm pktiotkldjdty rikrtdaujktis tbi quistdmo kshi` do O\@A

    IKV ;4

    aurdkj gioisds mc tbi jkogukgi (lut omt tbi prkatdai);19  mc ‒ameemo jkweitbm`mjmgy— ds do Crioab AN—s nu`geiot do Kpmtix. Pbi rijivkot siatdmo mcCrioab AN—s nu`geiot ds tdtji` ‒Vktiotkldjdty mc ei`dakj trikteiots ‑ K‚ameemo jkw― quistdmo=—.;13 Do Kpmtix , Crioab AN ujtdektijy cmuo` tbkt eitbm`s

    mc ei`dakj trikteiot mc bueko lidogs wiri pktiotklji sulniat ekttir ks dt wksomt jmgdakjjy ko` omrektdvijy ambiriot tm ixaju`i suab trikteiots wbiokppjydog tbi ekooir mc ekouckaturi ameemo jkw eitbm`mjmgy. ;17 

    Do suppmrt mc wby tbi amurts sbmuj` iogkgi do suab ameemo jkweitbm`mjmgdakj riksmodog, Crioab AN do Kpmtix  riksmoi` tbkt k ‒prmaissabkrkatirdstda— mc tbi ameemo jkw ds aksi-ly-aksi `iadsdmo ekhdog.;12 Crioab ANbij` tbkt tbds prmaiss>

    …ds kjsm k abkrkatirdstda mc tbi kppjdaktdmo ly amurts mc lrmk`jy stkti` stktutmryprmvdsdmos, tbi dotirpritktdmo, cjisbdog mut, ko` kppjdaktdmo mc wbdab tbijigdsjkturi bks jict tm tbi amurts.;14 

    Pbds kokjysds ds edrrmri` ly Crioab AN—s bmj`dog do @—Kray tbkt s ;2(;)(k) mc tbiKat prisardlis ‒lrmk` tixtukj pkrkeitirs wdtbdo wbdab prdoadpjis mc jkw kri tm li ksairtkdoi`, kppjdi` ko` `ivijmpi`—.;06  Pbus @—Kray  ds kutbmrdty cmr tbiprmpmsdtdmo tbkt tbds nustdcdaktdmo mc tbi ameemo jkw eitbm` jdis do tbidobiriotjy amepjix kppjdaktdmo mc tbisi jigkj prdoadpjis rigkr`dog pktiotkldjdty,wbdab kri ‒prigokot wdtb rujis ko` kppjdaktdmos kwkdtdog `dsamviry—.;0; Dt cmjjmwstbkt ‒XaUksi-ly-aksi `iadsdmo-ekhdog—;0

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    22/26

     Nmurokj mc Jkw, Docmrektdmo ko` Qadioai Smj

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    23/26

    @—Kray v Eyrdk` Gioitdas Doa X Pbi pjurkjdty—s oiw ckatmrdkj kpprmkab tm pktiotkldjdty rikrtdaujktis tbi quistdmo kshi` do O\@A

    IKV Dotrm`uatdmo mc uoairtkdoty dotmtbi jkw wdtb rispiat tm mtbir typis mc lmr`irjdoi sulniat ekttir=

    Ameeiotkry cmjjmwdog @—Kray  kppikrs smeiwbkt uodti` mo tbi pmdot tbkt dtdotrm`uais k `igrii mc uoairtkdoty dotm Kustrkjdko pktiot jkw cmr mtbir typis mcsulniat ekttir kt tbi lmr`irjdoi mc pktiotkldjdty.;93 Pbi emst prmedoiot ixkepjids k ameputir-depjieioti` lusdoiss eitbm`. Wbitbir suab ko doviotdmo dspktiotklji sulniat ekttir bks liio riaiotjy amosd`iri` ly twm Cujj Ci`irkjAmurt `iadsdmos. Cdrst, \isikrab Kccdjdktis JJA v Ameedssdmoir mc Vktiots;97  ko`siamo`, \VJ;92 (ks `dsaussi` klmvi do Vkrt

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    24/26

     Nmurokj mc Jkw, Docmrektdmo ko` Qadioai Smj

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    25/26

    @—Kray v Eyrdk` Gioitdas Doa X Pbi pjurkjdty—s oiw ckatmrdkj kpprmkab tm pktiotkldjdty rikrtdaujktis tbi quistdmo kshi` do O\@A

    IKV

  • 8/18/2019 D’Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality’s new factorial approach to patentability rearticulates th…

    26/26

     Nmurokj mc Jkw, Docmrektdmo ko` Qadioai Smj